2017-03-21,Cyclacel Pharmaceuticals To Release Fourth Quarter And Full Year 2016 Financial Results
2017-03-07,Cyclacel's CDK Inhibitor CYC065 Causes Anaphase Catastrophe, A Novel Cancer-Specific Mechanism Of Action, In Research Published In JNCI
2017-02-23,Biotech Movers: Shire Rises on Encouraging Angioedema Results
2017-02-23,Cyclacel Announces Top-Line Results From Pivotal Phase 3 SEAMLESS Study In Elderly Patients With Acute Myeloid Leukemia
2017-02-07,Cyclacel Pharmaceuticals' Preferred Stock Shares Cross 9% Yield Mark
2017-02-06,Cyclacel Pharmaceuticals To Present At The 19th Annual BIO CEO & Investor Conference
2016-12-01,Cyclacel's Novel PLK1 Inhibitor, CYC140, Demonstrates Therapeutic Potential In Esophageal Cancer And Acute Leukemia
2016-11-18,Moleculin Biotech gets good verbal Ok from FDA which should cut time to Phase 1/2 trial down
2016-11-14,Cyclacel Pharmaceuticals Reports 3rd Quarter 2016 Financial Results
2016-11-08,Cyclacel Pharmaceuticals's Preferred Stock Shares Cross 9% Yield Mark
2016-11-07,Cyclacel Pharmaceuticals To Release Third Quarter 2016 Financial Results
2016-09-06,Cyclacel's CYC065 Demonstrates Promising Activity In MYCN-Addicted Neuroblastoma In Preclinical Data Presented At Childhood Cancer 2016
2016-08-22,Cyclacel Stock Runs on Momentum Rocket Fueled by 'Dumb &amp; Dumber' Optimism
2016-08-22,Here's Why Cyclacel Pharmaceuticals (CYCC) Stock Is Surging Today
2016-08-12,Cyclacel Pharmaceuticals (CYCC) Stock Pops, H.C. Wainwright Bullish
2016-08-10,Cyclacel Pharmaceuticals Reports 2nd Quarter 2016 Financial Results
2016-08-03,Cyclacel Pharmaceuticals To Release Second Quarter 2016 Financial Results
2016-08-02,Cyclacel's CYC065 Demonstrates Promising Activity In Uterine Serous Carcinoma In Preclinical Data Published By Independent Academic Researchers
2016-06-16,Cyclacel Regains Compliance With Nasdaq Continued Listing Requirements
2016-06-06,Cyclacel Reports Updated Data From Its DNA Damage Response Program On Seliciclib And Sapacitabine Combination In Patients With Solid Tumors At ASCO
2016-05-27,Cyclacel Announces Reverse Stock Split
2016-05-19,Cyclacel's Seliciclib-Sapacitabine Abstract Selected For Oral Presentation At The 2016 American Society Of Clinical Oncology (ASCO) Annual Meeting
2016-05-11,Cyclacel Pharmaceuticals Reports First Quarter 2016 Financial Results
2016-05-04,Cyclacel Pharmaceuticals To Release First Quarter 2016 Financial Results
2016-04-18,Cyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Is An Effective Inducer Of Cell Death In B-cell Lymphoma And Synergizes With Bcl-2 Or BET Inhibitors
2016-04-11,Cyclacel Announces Receipt Of Nasdaq Extension
2016-03-24,Cyclacel Pharmaceuticals Reports Fourth Quarter And Full Year 2015 Financial Results
2016-03-17,Cyclacel Pharmaceuticals To Release Fourth Quarter And Full Year 2015 Financial Results
2016-03-01,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Breaches Of Fiduciary Duty By The Board Of Cyclacel Pharmaceuticals, Inc.
2016-02-05,Cyclacel Announces Receipt Of Nasdaq Staff Determination; Company To Request Hearing
2016-02-02,Cyclacel Pharmaceuticals To Present At The 18th Annual BIO CEO & Investor Conference
2016-01-11,Cyclacel Reviews 2015 Achievements And Announces Key Business Objectives For 2016
2015-12-14,Molecular Basis For Development Of Cyclacel's CYC065 CDK2/9 Inhibitor In Triple-Negative Breast Cancer Presented At San Antonio Breast Cancer Symposium
2015-11-23,CYC065, Cyclacel's Novel CDK2/9 Inhibitor, Prolongs Survival In MYCN-Addicted Neuroblastoma Models
2015-11-12,Cyclacel Pharmaceuticals Reports Third Quarter 2015 Financial Results
2015-11-09,Mechanistic Rationale For CYC065, Cyclacel's CDK2/9 Inhibitor, In Targeted Solid Tumors And Hematological Malignancies Presented At AACR-NCI-EORTC International Conference
2015-11-05,Cyclacel Pharmaceuticals To Release Third Quarter 2015 Financial Results
2015-10-26,Data To Be Presented On CYC065, Cyclacel's CDK2/9 Inhibitor, At AACR-NCI-EORTC International Conference
2015-10-22,Cyclacel Doses First Patient In Phase 1 Trial Of Its Novel CDK2/9 Inhibitor, CYC065, For The Treatment Of Advanced Solid Tumors
2015-09-17,Cyclacel Presents Molecular Rationale For Clinical Development Of CYC065 CDK Inhibitor In Leukemias And Lymphomas
2015-09-03,Cyclacel Pharmaceuticals To Present At Rodman & Renshaw 17th Annual Global Investment Conference
2015-08-11,Cyclacel Pharmaceuticals Reports Second Quarter 2015 Financial Results
2015-08-05,Cyclacel Pharmaceuticals To Release Second Quarter 2015 Financial Results
2015-07-02,First Patient Dosed In IST Of CDK Inhibitor Seliciclib In Cushing's Disease, A Serious Endocrine Disorder
2015-06-29,Cyclacel & ManRos Therapeutics Announce Licensing & Supply Agreement Regarding Development Of Seliciclib In Cystic Fibrosis
2015-06-19,5 Stocks Ready for Breakouts
2015-06-17,Cyclacel Pharmaceuticals To Present At 10th Annual JMP Securities Healthcare Conference
2015-05-12,Cyclacel Pharmaceuticals Reports First Quarter 2015 Financial Results
2015-05-05,Cyclacel Pharmaceuticals To Release First Quarter 2015 Financial Results
2015-04-20,Cyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential And Synergy With Other Anti-Cancer Compounds
2015-04-14,3 Stocks Under $10 to Trade for Breakouts
2015-03-24,Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2014 Financial Results
2015-03-20,Cyclacel's CYC065 Featured In Presentations At The American Association For Cancer Research Annual Meeting 2015
2015-03-17,Cyclacel Pharmaceuticals To Release Fourth Quarter And Full Year 2014 Financial Results
2015-03-12,Constellium Climbs Despite Q4 Loss
2015-03-04,Autohome Surges On 2014 Results Numbers
2015-03-04,Cyclacel Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
2015-03-03,Orexigen Surges - Even If Regulators Aren't Happy About It
2015-03-03,Cyclacel Pharmaceuticals Announces Proposed Public Offering Of Common Stock
2015-03-02,Leon Cooperman Gets A Boost Off Of NXP Semiconductors Surge
2015-03-02,Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels
2015-02-26,Penn Virginia Takes George Soros' Advice, Surges
2015-02-04,Staples Dips Down After Yesterday's Surge
2015-02-03,Cyclacel Pharmaceuticals To Present At The 17th Annual BIO CEO & Investor Conference
2015-01-06,Cyclacel Pharmaceuticals To Present At The Biotech Showcase(TM) 2015 Conference
2015-01-03,Billionaires Got Burned by These Six Struggling Stocks in 2014
2014-12-16,Cyclacel Announces Enrollment Of 486 Patients, DSMB Recommendations And That The Seamless Phase 3 Trial Of Sapacitabine In AML Will Continue To Final Analysis
2014-11-11,Cyclacel Pharmaceuticals Reports Third Quarter 2014 Financial Results
2014-11-04,Cyclacel Pharmaceuticals To Release 2014 Third Quarter Financial Results
2014-10-09,Cyclacel Announces Data Safety Monitoring Board Recommendation To Continue The Seamless Phase 3 Trial Of Sapacitabine In AML
2014-09-19,Cyclacel To Present At BioCentury's Newsmakers In The Biotech Industry Conference
2014-09-18,Cyclacel's CYC065 CDK Inhibitor Demonstrates Therapeutic Potential In Acute Leukemias With Mixed Lineage Leukemia (MLL) Rearrangements
2014-09-11,Cyclacel Pharmaceuticals Appoints Samuel L. Barker, Ph.D., To Board Of Directors
2014-09-10,Cyclacel Announces Abstract Selected For Presentation At Society Of Hematologic Oncology Annual Meeting
2014-09-02,Cyclacel Pharmaceuticals To Present At 16th Rodman & Renshaw Annual Global Investment Conference
2014-08-12,Cyclacel Pharmaceuticals Reports Second Quarter 2014 Financial Results
2014-08-06,Cyclacel Pharmaceuticals To Release 2014 Second Quarter Financial Results
2014-06-17,Cyclacel Pharmaceuticals To Present At 9th Annual JMP Securities Healthcare Conference
2014-05-31,Cyclacel Pharmaceuticals Provides Update On Its Clinical Development Plan Of Sapacitabine For Myelodysplastic Syndromes (MDS)
2014-05-28,Cyclacel Pharmaceuticals To Webcast Institutional Investor And Analyst Presentation On Clinical Development Plan Of Sapacitabine For MDS
2014-05-13,Cyclacel Pharmaceuticals Reports First Quarter 2014 Financial Results
2014-05-06,Cyclacel Pharmaceuticals To Release 2014 First Quarter Financial Results
2014-05-05,New Japanese Patents Issued Covering Sapacitabine Pharmaceutical Formulations And Combination Treatments
2014-04-10,Independent Investigators Present Non-Clinical Data Providing Rationale For Sapacitabine Combination Treatment With Bcr-Abl Inhibitors In CML
2014-04-09,Cyclacel Pharmaceuticals, Inc. Announces Closing Of $10 Million Underwritten Offering
2014-04-04,Cyclacel Pharmaceuticals Announces $10 Million Underwritten Offering
2014-04-03,Cyclacel Pharmaceuticals Announces Proposed Public Offering Of Common Stock
2014-03-25,Cyclacel Pharmaceuticals Reports Fourth Quarter And Full Year 2013 Financial Results
2014-03-13,Cyclacel Pharmaceuticals To Release Fourth Quarter And Full Year 2013 Financial Results
2014-02-03,Cyclacel Pharmaceuticals To Present At The 16th Annual BIO CEO & Investor Conference
2014-01-13,Cyclacel Reviews 2013 Achievements And Announces Key Business Objectives For 2014
2014-01-06,Cyclacel Pharmaceuticals To Present At Biotech Showcase(TM) 2014 Conference
2013-12-31,Cyclacel Pharmaceuticals's 6% Preferred Stock Yield Pushes Past 6.5%
2013-12-09,Cyclacel Reports New Phase 2 Data Of Sapacitabine For MDS At ASH
2013-11-25,Cyclacel Announces Data Safety Monitoring Board Recommendation To Continue The SEAMLESS Phase 3 Trial Of Sapacitabine In AML
2013-11-19,First Week Of July 2014 Options Trading For Cyclacel Pharmaceuticals (CYCC)
2013-11-12,Cyclacel Reports Third Quarter 2013 Financial Results
2013-11-07,Researchers To Present New Phase 2 Data On Sapacitabine As A Treatment For Patients With MDS At ASH Annual Meeting
2013-11-06,Cyclacel Pharmaceuticals To Release Third Quarter 2013 Financial Results
2013-11-05,New US Patents Issued Covering Sapacitabine Use With Hypomethylating Agents And Sapacitabine Dosing Regimens
2013-10-31,Cyclacel Pharmaceuticals To Present At The 2013 Therapeutic Area Partnerships Conference
2013-10-15,Cyclacel Pharmaceuticals Convertible Exchangeable Preferred Stock Ex-Dividend Reminder - 10/17/13
2013-09-27,First Week Of November 16th Options Trading For Cyclacel Pharmaceuticals (CYCC)
2013-09-19,Cyclacel's Sapacitabine Reported To Have Anti-Tumor Activity Against Ovarian Cancer
2013-08-14,Cyclacel Reports Second Quarter 2013 Financial Results
2013-08-12,Cyclacel's Seliciclib To Be Evaluated In Investigator-Initiated Clinical Study To Treat Rheumatoid Arthritis
2013-08-08,Cyclacel Pharmaceuticals To Announce Release Of Second Quarter 2013 Financial Results
2013-07-05,Cyclacel Pharmaceuticals To Present At The JMP Securities Healthcare Conference 2013
2013-05-29,5 Stocks Insiders Love Right Now
2013-05-23,Top Insider Trades: RH, AMBI, LULU, CYCC
2013-05-21,Cyclacel Pharmaceuticals Announces Closing Of Underwritten Offering
2013-05-16,Cyclacel Pharmaceuticals Announces $20 Million Underwritten Offering
2013-05-15,Cyclacel Pharmaceuticals Announces Proposed Public Offering Of Common Stock
2013-05-13,Cyclacel Reports First Quarter 2013 Financial Results
2013-05-10,Cyclacel Pharmaceuticals To Announce Release Of First Quarter 2013 Financial Results
2013-04-30,Cyclacel Reports Updated Phase 2 Survival Data Of Sapacitabine For MDS
2013-04-23,Cyclacel Pharmaceuticals To Present At The 12th Annual Needham Healthcare Conference
2013-04-16,Reminder: Cyclacel Pharmaceuticals' 6% Preferred Stock Goes Ex-Dividend Soon
2013-04-09,Combination Potential Of Cyclacel's Sapacitabine And Seliciclib Reported At AACR
2013-04-08,AACR Press Conference Highlights Combination Potential Of Two Cyclacel Drugs
2013-04-04,Cyclacel Announces Sale Of Four Cyclacel Romidepsin-Related Patents To Celgene And Dismissal Of All Claims In Their Patent Litigation
2013-04-03,Cyclacel Announces Multiple Abstracts Selected For Presentation At American Association For Cancer Research Annual Meeting
2013-03-27,Cyclacel Pharmaceuticals Reports Fourth Quarter And Full Year 2012 Financial Results
2013-03-25,5 Stocks Set to Soar on Bullish Earnings
2013-03-22,Cyclacel To Announce Year-End And Fourth Quarter 2012 Financial Results
2013-02-12,Cyclacel Announces Grants Of New U.S. & European Patents Covering Sapacitabine Used In Combination With HDAC Inhibitors
2013-02-04,Cyclacel Pharmaceuticals To Present At The 15th Annual BIO CEO & Investor Conference
2013-01-25,4 Stocks Under $10 Moving Higher
2013-01-07,Cyclacel Reviews 2012 Achievements And Announces Key Business Objectives For 2013
2012-12-17,Cyclacel Enters Into A $20 Million Common Stock Purchase Agreement With Aspire Capital Fund, LLC
2012-12-10,Cyclacel Presents Updated Survival Data From The Pilot Study And Lead-In Phase Of Seamless Phase 3 Study At The 2012 ASH Annual Meeting
2012-10-25,4 Biotech Stocks Under $10 Moving Higher
2012-10-19,5 Stocks Ready to Break Out
2012-10-17,How to Prep for the Inevitable Bursting of the Biotech Stock Bubble
2012-10-15,Cyclacel's Sapacitabine Nearly Doubles Expected Survival Of Elderly Patients With MDS After Front-Line Therapy Failure
2012-10-12,Updated Phase 2 Survival Data Of Cyclacel's Sapacitabine For MDS Presented At The Eighth Annual Hematologic Malignancies 2012 Conference
2012-10-02,Cyclacel To Present At BIO Investor Forum
2012-09-21,Biotech Stock Mailbag: Pending Sarepta Results, Cyclacel
2012-09-19,Biotech Stock Live Chat: Fall Preview
2012-09-13,Cyclacel Regains Compliance With NASDAQ Minimum Bid Price Listing Requirement
2012-09-11,4 Biotech Stocks Under $10 Making Big Moves
2012-08-29,Cyclacel To Present At Stifel Nicolaus 2012 Healthcare Conference
2012-08-24,Cyclacel Announces Reverse Stock Split
2012-08-14,Cyclacel Pharmaceuticals Management Discusses Q2 2012 Results - Earnings Call Transcript
2012-08-14,Cyclacel Reports Second Quarter 2012 Financial Results
2012-08-10,Cyclacel Pharmaceuticals To Announce Release Of Second Quarter 2012 Financial Results
2012-03-02,Friday's Top 10 Articles, Videos on TheStreet
2012-03-02,Biotech Stock Mailbag: Cyclacel Fallout, the Skinny on Vivus, Celldex's Crash
2012-02-13,BIO CEO Conference Live Blog
2011-12-09,The Worst Biotech CEO of 2011 Is ...
2011-11-16,The Biotech Stock 13F Review: What Hedge Funds Were Buying and Selling
2011-10-07,Biotech Stock Mailbag: Somaxon, Transcept
2011-09-30,Biotech Stock Mailbag: Research Backs Shorting Micro-Cap Cancer Drug Stocks
2011-08-12,Biotech Stock Mailbag: Cyclacel Pharma
2011-08-08,Cyclacel Stock Gaps Down On Today's Open (CYCC)
2011-07-01,Biotech Stock Mailbag: Ranking Cheap Biotechs
2011-06-28,10 Cheap Biotech Stocks That Could Soar
2011-05-19,ASCO: Traders Love Speculative Cancer Stocks
2011-03-29,Cyclacel Announces Abstracts Selected For Presentation At American Association For Cancer Research Annual Meeting
2011-03-25,Biotech Stock Mailbag: Bio-Hazards
2011-03-23,Cyclacel Pharmaceuticals Reports Fourth Quarter And Full Year 2010 Financial Results
2011-03-07,Cyclacel Pharmaceuticals To Announce Year End & Fourth Quarter 2010 Financial Results And Presentation At Upcoming Conference
2011-02-17,Data Published In The Proceedings Of The National Academy Of Sciences Highlight The Potential Of Cyclacel's Targeted CDK Inhibitors In Breast Cancer
2011-02-01,Cyclacel Pharmaceuticals To Present At The 13th Annual BIO CEO & Investor Conference
2011-01-11,Cyclacel Begins Pivotal Phase 3 "SEAMLESS" Trial Of Sapacitabine As Front-Line Treatment For AML Under A Special Protocol Assessment
2011-01-06,Cyclacel Reviews 2010 Achievements And Key Clinical Development Objectives For 2011
2010-12-21,Cyclacel Announces Topline Results From The Appraise Phase 2b Study Of Seliciclib In Heavily-Pretreated Patients With Non-Small Cell Lung Cancer
2010-12-05,Cyclacel's Second Generation Cyclin-Dependent Inhibitor CYC065 Demonstrates Activity In Multiple Myeloma
2010-12-04,Cyclacel Reports Phase 2 Survival Data With Sapacitabine In Myelodysplastic Syndromes At 2010 ASH Annual Meeting
2010-11-19,Cyclacel Pharmaceuticals To Present Sapacitabine Phase 2 MDS Data At The Upcoming American Society Of Hematology Meeting
2010-11-12,Cyclacel To Present At Upcoming Conferences
2010-11-11,Cyclacel Pharmaceuticals Reports Third Quarter 2010 Financial Results
2010-11-10,Publications Highlight Novel Combinations Of Sapacitabine With Targeted Agents For The Treatment Of Cancer
2010-11-04,Cyclacel Pharmaceuticals To Announce Release Of Third Quarter 2010 Financial Results
2010-10-08,Biotech Stock Mailbag: Cyclacel Pharma
2010-10-07,Cyclacel Completes Previously Announced Private Placement
2010-10-06,Cyclacel Announces Adjournment Of Special Preferred Stockholders Meeting
2010-10-05,Cyclacel Announces Private Placement Financing For Up To $22.1 Million
2010-09-29,Cyclacel To Present At BIO Investor Forum
2010-09-13,Ariad, Cyclacel To Start Key Drug Trials
